Lilly begins first clinical trial of antibody that targets SARS-CoV-2
Friday, June 5, 2020 - 18:50
in Health & Medicine
The antibody, isolated by the Canadian start-up AbCellera, was discovered and developed in just 3 months
The antibody, isolated by the Canadian start-up AbCellera, was discovered and developed in just 3 months